Pan-cancer analysis indicates that MYBL2 is associated with the prognosis and immunotherapy of multiple cancers as an oncogene
Authors:
- 29 September 2021
- journal article
- research article
- Published by Taylor & Francis in Cell Cycle
- Vol. 20 (21) , 2291-2308
Abstract
MYBL2 has been demonstrated to be an oncogene in some cancers, but there is no pan-cancer analysis at the macro level. We used multiple online or offline bioinformatic tools to examine the effects of MYBL2 in human cancers. We first identified that MYBL2 was highly expressed and related to the stage and grade of most cancers. The results of survival analysis from two databases showed that high MYBL2 expression was positively correlated with a poor prognosis for most cancer patients. We observed a significant difference in the promoter methylation level of MYBL2 in cancers such as colon adenocarcinoma and liver hepatocellular carcinoma versus normal controls. We found that MYBL2 can affect the tumor immune microenvironment by influencing the immune infiltration level and expression level of CD4+ T cells, CD8+ T cells, cancer-associated fibroblasts (CAFs) and immune checkpoint-associated cells. Functional enrichment analysis of MYBL2 identified that MYBL2 can play a crucial role in cancers by regulating spliceosomes, DNA replication and the cell cycle. Moreover, we verified the function of MYBL2 in three cancer cells of glioma, breast cancers and liver cancers, and the results showed that MYBL2 can regulate the cell cycle and proliferation ability of cancersKeywords
Funding Information
- National Natural Science Foundation of China (81172405)
- Tianjin Municipal Science and Technology Committee (18JCZDJC98600)
- Science and Technology Fund of Tianjin Binhai New Area Health and Family Planning Commission (2018BWKZ002)
This publication has 50 references indexed in Scilit:
- Innate and adaptive immune cells in the tumor microenvironmentNature Immunology, 2013
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortalScience Signaling, 2013
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- The cell cycle and cancerThe Journal of Pathology, 2011
- MYBL2, a link between proliferation and differentiation in maturing colon epithelial cellsJournal of Cellular Physiology, 2010
- Microsatellite instability in colorectal cancer—the stable evidenceNature Reviews Clinical Oncology, 2010
- Fibroblasts in cancerNature Reviews Cancer, 2006
- Evidence for an instructive mechanism of de novo methylation in cancer cellsNature Genetics, 2006
- Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomasBlood, 2003
- The myb gene family in cell growth, differentiation and apoptosisOncogene, 1999